The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
CD40 ligand/interferon-γ matured DC immunization with gp100 antigen HLA class I  A *0201 restricted peptides in patients with newly diagnosed metastatic melanoma.
Gerald P. Linette
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Roche/Genentech
Michelle Becker-Hapak
No relevant relationships to disclose
Alexander Huang
No relevant relationships to disclose
Amer Alyasiry
No relevant relationships to disclose
Megan Chan
No relevant relationships to disclose
Wen-rong Lie
Employment or Leadership Position - EMD Millipore
Lynn Cornelius
No relevant relationships to disclose
Jeffrey F. Moley
No relevant relationships to disclose
Rebecca Aft
No relevant relationships to disclose
Benjamin R. Tan
No relevant relationships to disclose
Kathryn Trinkaus
No relevant relationships to disclose
Beatriz M Carreno
No relevant relationships to disclose